Osteoartroz i metabolicheskiy sindrom


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The problem of osteoarthrosis (OA) and metabolic syndrome (MS) has become urgent now due to increased frequency of obesity and an increase in life expectancy. In the literature, there is evidence on the relationship of OA with metabolic disorders. The main cause of MS is insulin resistance, which starts a vicious circle of symptoms eventually leading to the development of complications, in particular to the initiation and progression of OA. The review describes the recent literature data on the relationship of OA and MS, shows the role of weight loss on the clinical manifestations of OA.

Full Text

Restricted Access

References

  1. Centers for Disease Control and Prevention (CDC). Prevalence and most common causes of disability among adults - United States, 2005. MMWR Morb. Mortal. Wkly. Rep. 2009;58(16):421-26.
  2. Woolf A., Pfleger B. Burden of major musculoskeletal conditions. Bull. World. Health Organ. 2003;81(9):646e56.
  3. Алексеева Л.И. Препараты замедленного действия в лечении остеоартроза. РМЖ. 2012;7: 389-93.
  4. Галушко Е.А. Медико-социальная значимость ревматических заболеваний. Дисс. докт. мед. наук. М., 2013.
  5. Lee R., Kean F. Obesity and knee osteoarthritis. Inflammopharmacology. 2012;20(2):53-8.
  6. Bijlsma J., Berenbaum F., Lafeber P. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783): 2115-26.
  7. Консервативное лечение остеоартроза. Руководство. Под ред. С.М. Носкова. М., 2014. 10 с.
  8. Dinarello C. Overview of the interleukin-1 family of ligands and receptors. Semin. Immunol. 2013;25(6):389-93.
  9. Afonso V., Champy R., Mitrovic D., Collin P., Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint. Bone. Spine. 2007;74(4):324-29.
  10. Massicotte F., Lajeunesse D., Benderdour M. Can altered production of interleukin-1ß, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identity two subgroups of osteoarthritic patients. Osteoarthritis and Cartilage. 2002;10(6):491-500.
  11. Saklatvala J. Tumour necrosis factor β stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 1986;322(6079):547-49.
  12. Цурко В.В., Хитров Н.А. Остеоартроз: патогенез, клиника, лечение. Лечащий врач. 2000;9: 30-8.
  13. Sowers M., Jannausch M., Stein E., Jamadar D., Hochberg M., Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage. 2002;10(8):595-601.
  14. Toussirot E., Streit G., Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases, Current. Medicinal Chemistry. 2007;14(10):1095-100.
  15. Felson D., Lawrence R., Dieppe P., Hirsch R., HelmickC.G.,Jordan J.M., KingtonR.S., Lane N.E., Nevitt M.C., Zhang Y., Sowers M., McAlindon T., Spector T.D., Poole A.R., Yanovski S.Z., Ateshian G., Sharma L., Buckwalter J.A., Brandt K.D., Fries J.F. Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors FREE. Ann. Intern. Med. 2000;133(8):635-46.
  16. Jiang L., Tian W., Wang Y., Rong J., Bao C., Liu Y., Zhao Y., Wang C. Body mass index and susceptibility to knee osteoarthritis: a systematic review and meta-analysi. Joint Bone Spine. 2012;79(3):291-97.
  17. Toivanen A., Heliövaara M., Impivaara O., Arokoski J.P., Knekt P., Lauren H., Kröger H. Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis--a population-based study with a follow-up of 22 years. Rheumatology (Oxford). 2010;49(2):308-14.
  18. Reijman M., Pols H., Bergink A., Hazes J.M., Belo J.N., Lievense A.M., Bierma-Zeinstra S.M. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: The Rotterdam Study. Ann. Rheum. Dis. 2007;66:158-62.
  19. Manek N., Hart D., Spector T., MacGregor A. The association of body mass index and osteoarthritis of the knee joint: an examination of genetic and environmental influences. Arthritis Rheum. 2003;48(4):1024-29.
  20. Grotle M., Hagen K., Natvig B., Dah F., Kvien T. Obesity and osteoarthritis in knee, hip and/ or hand: An epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008;9:132.
  21. Lievense A, Bierma-Zeinstra S., Verhagen A., van Baar M.E., Verhaar J.A., Koes B.W. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology (Oxford). 2002;41(10):1155-62.
  22. Carman W., Sowers M., Hawthorne V., Weissfeld L. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am. J. Epidemiol. 1994;139(2):119-29.
  23. Zhuo Q., Yang W., Chen J., Wang Y. Metabolic syndrome meets osteoarthritis. Nat. Rev. Rheumatol. 2012;8(12):729-37.
  24. IDF. The IDF consensus worldwide definition of the metabolic syndrome. 2006.
  25. Puenpatom R., Victor T. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANESIII data. Postgrad. Med. 2009;121(6):9-20.
  26. Yoshimura N., Muraki S., Oka H., Tanaka S., Kawaguchi H., Nakamura K., Akune T. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage. 2012;20(11): 1217-26.
  27. Sowers M., Karvonen-Gutierrez C.A., Palmieri-SmithR.,JacobsonJ.A.,JiangY.,Ashton-MillerJ.A. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum. 2009;61(10):1328-36.
  28. Dahaghin S., Bierma-Zeinstra S., Koes B. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann. Rheum. Dis. 2007;66: 916-20.
  29. Красивина И.Г. Особенности гонартроза у больных ожирением и сахарным диабетом. Международный эндокринологический журнал. 2011;3:113-23.
  30. Супрун Э.В. Коморбидность при остеоартрозе у пожилых пациентов: выбор тактики лечения. Рациональная фармакотерапия. 2013;3(28):47-52.
  31. Денисов Л.Н., Насонова В.А. Ожирение и остеоартроз. Научно-практическая ревматология. 2010;3:48-51.
  32. Findlay D. Vascular pathology and osteoarthritis. Rheumatology (Oxford). 2007;46:1763-68.
  33. Ibrahim M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 2010;11(1):11-8.
  34. Eymard F., Parsons C., Edwards M., Petit-Dop F., Reginster J.Y., Bruyere O., Richette P., Cooper C., Chevalier X. Diabetes is a risk factor for knee osteoarthritis progression. Osteoarthritis Cartilage. 2015;S1063-4584(15)00026-6.
  35. Рекомендации экспертов Всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома. Второй пересмотр. Кардиоваскулярная терапия и профилактика. 2009;6(Прил. 2):1-29.
  36. National Institutes of Health, National Heart Lung and Blood Institute. Evaluation, and Treatment of Overweight and Obesity in Adults. Clinical Guidelines on the Identification. 1998;98-483.
  37. Messier S., Mihalko S., Legault C., Miller G.D., Nicklas B.J., DeVita P., Beavers D.P., Hunter D.J., Lyles M.F., Eckstein F., Williamson J.D., Carr J.J., Guermazi A., Loeser R.F. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;25;310(12):1263-73.
  38. Савельева Л.В. Современная концепция лечения ожирения: клинические рекомендации для практикующих врачей. Фарматека. 2007;12:33-8.
  39. Tsigosa C., Hainerb V., Basdevantc A., Finer N., Fried M., Mathus-Vliegen E., Micic D., Maislos M., Roman G., Schutz Y., Toplak H., Zahorska-Markiewicz B.; Obesity Management Task Force of the European Association for the Study of Obesity. Management of Obesity in Adults: European Clinical Practice Guidelines. Obesity. Facts. 2008;1:106-16.
  40. Бондаренко И.З., Бутрова С.А., Гончаров Н.П. Лечение морбидного ожирения. Национальные клинические рекомендации. Ожирение и метаболизм. 2011;3: 75-83.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies